» Some users from Germany?? We can contact them and ask something.
» another site about batra and hoffmann, of february 2008
I translated the link to Hoffmans home page using Windows Live translator.
It really isn’t that intersting, The first page is just like a journal of what Dr Hoffman has been up to since 2004, there is some mention of india and stem cell technology but there isn’t a single mention from what I could see about HM on the rest of the site.
It just describes available treatments, talks about HT’s, Hoffmans tricho scan and other general dermotology etc.
Ill post only the bits relevent to HM.
The second link is a general article about the batra clinic and them planning on introducing HM with Dr Hoffman, Its English but ill copy and paste that one for good measure.
I found some more info on the website - www.trichotissue.com
Which looks like Dr Hoffmans hair transplant and laser therapy site.
Ill post that at the bottom, the translation is not very easy to understand.
22 July - 26. July 2008:
Prof. Hoffmann located on the training week in Munich. Before dermatologists speaks Prof. Hoffmann vapir to stem cell therapy in hair loss, trichocare and trichoscan.
30 January - 6. February 2008:
Prof. Hoffmann located on a lecture travel in India. Before dermatologist in newdelhi, Bangalore and Mumbai speaks Prof. Hoffmann vapir to stem cell therapy in hair loss.
- October 2007:
Mr Prof. Hoffmann speaks the occasion of the Conference “IX selection Reunión del Grupo Español de tricología” in Barcelona on stem cell technologies.
Mr Prof. Hoffmann reported in the Magazine “medical practice” on the stem cell technology in hair loss.
Bangalore, Feb. 5 Homeopathy therapist chain Dr Batra’s Clinic has said it plans to introduce hair cloning in a tie-up with German dermatologist, Dr Rolf Hoffmann.
Dr Mukesh Batra, Chairman and MD, Dr Batra’s Clinic, said, “Bringing cloning to India would be an ideal extension of our brand and would be a very good answer for all hair patients in India.”
Dr Hoffmann, credited with inventing the Trichoscan hair density meter and culturing hair in mice, said his process of hair cloning can become a reality for millions in a few years.
Batra’s is a potential partner with its large chain of homeopathy clinics and a large base of hair patients, he said.
All 275 doctors at Dr Batra’s clinics are being trained.
Affordable hair scanners were being launched. A scan now costs around Rs 2 lakh.
Dr Hoffmann, who is President of the European Hair Research Society, said the hair care market worldwide was estimated at $ 150 billion (around Rs 6,00,000 crore).
The hair transplant business is valued at $1.2 billion (Rs 4,200 crore) and an estimated 7,00,000 patients visit a transplant surgeon each year, according to him. "
"State of development
New developments to hair follicle stem cells can hope that new treatment options.
For many years know that cells of the hair root (so-called dermal papilla, papillenzellen) are able, after cell culture and spritzung into the skin new hair. Prevalance that the so-called adult mesenchymale stem cells of hair, the hair growth in General taxes. Until a few years ago it was not possible, these cells in nutritional media to breed which free animalistic components. We use any materials on nutritional media what still animal components. Long testungen we succeeded, completely biotechnically - dial nutritional media to develop, in which the hair root cells optimally grow.
Own studies have shown that cells in the direct vicinity of the hair root, after injection into the skin considerably better hair growth created and that in comparison with cells of the hair papilla this hair growth also longer. Because these cells hundenasen root cups like umscheiden, we have you cups called. In our experiments we show that,
Who hair cells in turn whiskers in regions grow where only Downy hair was present;
the researchers injected cells in pre-existing hair roots and a dickeres hair;
after injection in not hairy skin (external) a hair growth to induce;
the - induced hair significantly longer and better delawares, as such hair, using papillenzellen induced.
In the sum, we believe that this "cups cells “ the real mesenchymalen stem cells of hair with inductive properties. The future will show whether such results when people as a kind of micro - hair transplantation recoverable.
The androgenetic alopecia is for women and men the most common form of hair loss. Although the hair loss Mrs and man clinically usually different show it the underlying, hair lessness leading mechanisms the same. It can assume that, due to genetic effigies certain hair follicle at the oberkopf enhanced sensitivity towards androgenes. The research results of recent years have a variety few diagnostically and therapeutic significant findings shows. It have established therapies we finasteride for the man and Rogaine (drug) solution for men and women. Ultimately it is this Therapeutics, what a hair loss in part.
The available medicines work best in early stages of androgenetic alopecia. Often notice patients only little effect, i.e. paralysis of hair loss. In advanced stages of androgenetic alopecia is the hair transplantation an effective therapy option.
With the time, advanced hair unemployment, is insufficient number of donors hair. Then is a hair transplantation no longer possible.
Here is an approach of biotechnological research, from the body’s own hair root cells new hair. With this body’s own cells in future be able, hair loss even more effective and friendly.
The preliminary inquiry and characterization of the cups cells is complete. Now there are several surface marker for a possibly GMP (good manufacturing practice) approval. Still we succeeded, the cells in a not animal medium anzuzüchten. All results to those cells are intellectual property with a patent application protected.
The technology transfer in a GMP - enabled laboratory at a manufacturing approval after GMP.
The plan for the future it is, with a manufacturing permission immediately pilot studies after the law (AMG). At this point we report about new developments."
Here are Babel Fish and Google translations of the last paragraph that are slightly different.;
The preliminary investigations and characterisation of the cup cells is final. Meanwhile different surface markers are GMP (good manufacturing practice) for one - permission at the disposal. Further we succeeded, which anzuzüchten cells in a not animal medium. All results to these cells are protected as mental property with a patent application.
The transfer of technology lines up into an GMP able laboratory, in order to request a manufacture permission after GMP.
The plan for the future is it to accomplish with a manufacture permission immediately pilot studies after the drug law (AMG). Here we report on new developments."
The preliminary studies and characterization of the cup cells has been completed. Meanwhile, various surface marker for a possible GMP (good manufacturing practice)-license available. Furthermore, we have succeeded, the cells in a medium non-animal anzuzüchten. All results to these cells are considered intellectual property with a patent-protected.
It is the technology into a GMP-compliant laboratory to a manufacturing license to apply for GMP.
immediately after the pilot studies Drug Law (AMG) to implement. At this point, we report on new developments.